Sabrina michelle

BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation

BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation

3 days ago   |   Xconomy

The US is doing more in the COVID-19 space than anywhere in the world due to the strength of its innovative ecosystem, says Michelle McMurry-Heath, president & CEO of life...
Read more ...

Q&A: BIO CEO Michelle McMurray-Heath Outlines Diversity Goals

Q&A: BIO CEO Michelle McMurray-Heath Outlines Diversity Goals

16 days ago   |   Xconomy

It would be hard to find a more challenging time for Michelle McMurry-Heath to join the Biotechnology Innovation Organization as its CEO given the COVID-19 pandemic and the...
Read more ...

Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday

Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday

20 days ago   |   Xconomy

Don't miss out on savings for this year's online Xcelerate Keynote Series at Biotech Week Boston - our early bird sale ends this Friday! Speakers include: Jeff Baker - Deputy...
Read more ...

FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines

FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines

27 days ago   |   Xconomy   |   4 articles

The FDA has authorized the use of plasma from people who have recovered from infection by the novel coronavirus as a treatment for hospitalized COVID-19 patients, a move widely...
Read more ...

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

1 month ago   |   Xconomy

AbbVie has terminated a research partnership with Editas Medicines, returning to the biotech rights to an experimental gene-editing treatment. It's the second genetic medicines...
Read more ...

Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More

Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More

3 monthes ago   |   Xconomy

At the start of 2020 thousands of biotechies anticipated spending the second week of June in San Diego, hobnobbing at the annual conference hosted by the Biotechnology...
Read more ...

Fauci Foresees “More Than 1 Winner” in Race for COVID-19 Vaccines, Drugs

Fauci Foresees “More Than 1 Winner” in Race for COVID-19 Vaccines, Drugs

3 monthes ago   |   Xconomy   |   2 articles

To ameliorate a pandemic that infectious disease expert Anthony Fauci calls his “worst nightmare,” a winner-takes-all solution won't be enough. Fauci, who directs the National...
Read more ...

Go Big or Go Home - Tackling a Giant Genome

Go Big or Go Home - Tackling a Giant Genome

5 monthes ago   |   Pacific Biosciences

California redwoods: Not only are they giants in height and age (up to 379 feet high, 29 feet round, and thousands of years old), but the famous towering trees are also derived...
Read more ...

Aerie Pharmaceuticals hires former Allergan, Alcon exec to help lead clinical, medical affairs

7 monthes ago   |   Fierce Biotech   |   2 articles

Michelle Senchyna, Ph.D., has been named as the new vice president for clinical development and medical affairs at eye disorder biotech Aerie Pharmaceuticals.
Read more ...

At PAG 2020, HiFi Data ‘Transformational' for Advancing Plant and Animal Research

At PAG 2020, HiFi Data ‘Transformational' for Advancing Plant and Animal Research

7 monthes ago   |   Pacific Biosciences

What better way to start the year than a gathering of thousands of stellar scientists? We were excited, once again, to attend the Plant and Animal Genome Conference in sunny...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Cend Therapeutics Announces Acquisition of Impilo Therapeutics

SAN DIEGO, Sept. 21, 2020 - Cend Therapeutics, Inc., a clinical-stage biotech company, announced today that it has acquired Impilo Therapeutics, Inc. The combination expands... Read more ...

SDBN Podcast: What is a Sales Agent and Do You Need One?

I met Owen Swift at an online networking event. I didn't know what a sales agent was or why a company would choose to use one, so I invited him to the podcast to explain... Read more ...

Your cells look young for their age, compared to a chimp's

Many humans live to see their 80s, some even reach 100. But chimpanzees rarely make it past 50, despite sharing 99% of our genetic code. While modern medicine has added years... Read more ...

Flagship Pioneering's 2-becomes-one biotech nabs ex-Pfizer CSO as research lead

Flagship Pioneering's 2-becomes-one biotech nabs ex-Pfizer CSO as research lead badams Mon, 09/21/2020 - 08:20 Read more ...

Peace Pilot Completes Pole-to-Pole Circumnavigation During Pandemic

SAN DIEGO-- citizenoftheworld-San Diego pilot & former Naval officer Robert DeLaurentis returns from global Pole-to-Pole peace mission. Sept. 21 named Citizen of the World Day.... Read more ...

Two wild weeks for Grail end in $8B Illumina buyout

Grail's whirlwind two weeks have ended in the wealthy arms of its former founder and benefactors. Illumina has shelled out $8 billion to reacquire the closely-watched liquid... Read more ...

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

SAN DIEGO & MENLO PARK, Calif.--- $ILMN ILMN-Illumina, Inc. and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have... Read more ...

Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in...

Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in hot field ntaylor Mon, 09/21/2020 - 05:42 Read more ...

Bachem: Chemist I

Bachem: Your Responsibilities Note: This position is for 1st or 2nd shift The Chemist function is to develop the peptide manufacture process, manufact Vista, CA, US ... Read more ...

Retrophin: Director, Regulatory Affairs

Retrophin: At Retrophin, our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. Giving patients a chance, pr San Diego... Read more ...